The role of receptor tyrosine kinase and activated PI3K signaling in response/resistance to HER-2 targeted therapy.

被引：0
|
作者：
O'Brien, N. A.
Browne, B. C.
Chow, L.
Ginther, C.
Bensadigh, B.
Arboleda, J.
Duffy, M. J.
Crown, J.
O'Donovan, N.
Slamon, D. J.
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Dublin City Univ, Dublin 9, Ireland
[3] St Vincents Univ Hosp, Dublin 4, Ireland
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：160S / 160S
页数：1
相关论文
共 50 条
  • [21] Potential of overcoming resistance to HER2-targeted therapies through the PI3K/Akt/mTOR pathway
    Wilks, Sharon T.
    BREAST, 2015, 24 (05): : 548 - 555
  • [22] Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy
    Saintigny, Pierre
    Mitani, Yoshitsugu
    Pytynia, Kristen B.
    Ferrarotto, Renata
    Roberts, Dianna B.
    Weber, Randal S.
    Kies, Merrill S.
    Maity, Sankar N.
    Lin, Sue-Hwa
    El-Naggar, Adel K.
    CANCER, 2018, 124 (18) : 3693 - 3705
  • [23] Activated cMyc/PIM kinase promotes resistance to PI3K/mTOR inhibition in NSCLC
    Moore, G.
    Heavey, S.
    O'Byrne, K.
    Cuffe, S.
    Finn, S. P.
    O'Neill, M.
    Gately, K.
    LUNG CANCER, 2018, 115 : S2 - S2
  • [24] Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy
    Wani, Atif Khurshid
    Singh, Reena
    Akhtar, Nahid
    Prakash, Ajit
    Nepovimova, Eugenie
    Oleksak, Patrik
    Chrienova, Zofia
    Alomar, Suliman
    Chopra, Chirag
    Kuca, Kamil
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (16) : 1496 - 1520
  • [25] Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma
    Scherschinski, Lea
    Prem, Markus
    Kremenetskaia, Irina
    Tinhofer, Ingeborg
    Vajkoczy, Peter
    Karbe, Anna-Gila
    Onken, Julia Sophie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (02)
  • [26] The Role of MAPK and PI3K/AKT/mTOR Signaling in Innate Lapatinib Resistance
    McDermott, M.
    O'Brien, N.
    McDonald, K.
    Crown, J.
    O'Donovan, N.
    Slamon, D.
    CANCER RESEARCH, 2011, 71
  • [27] NRF2 antioxidant signaling mediates the ability of PIM protein kinases to induce resistance of prostate cancer to PI3K inhibitor therapy.
    Song, Jin H.
    Leuvano, Libia A.
    Singh, Neha
    Kraft, Andrew S.
    CANCER RESEARCH, 2018, 78 (16) : 132 - 132
  • [28] Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer
    Mezynski, M. Janusz
    Farrelly, Angela M.
    Cremona, Mattia
    Carr, Aoife
    Morgan, Clare
    Workman, Julie
    Armstrong, Paul
    McAuley, Jennifer
    Madden, Stephen
    Fay, Joanna
    Sheehan, Katherine M.
    Kay, Elaine W.
    Holohan, Ciara
    Elamin, Yasir
    Rafee, Shereen
    Morris, Patrick G.
    Breathnach, Oscar
    Grogan, Liam
    Hennessy, Bryan T.
    Toomey, Sinead
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [29] Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer
    M. Janusz Mezynski
    Angela M. Farrelly
    Mattia Cremona
    Aoife Carr
    Clare Morgan
    Julie Workman
    Paul Armstrong
    Jennifer McAuley
    Stephen Madden
    Joanna Fay
    Katherine M. Sheehan
    Elaine W. Kay
    Ciara Holohan
    Yasir Elamin
    Shereen Rafee
    Patrick G. Morris
    Oscar Breathnach
    Liam Grogan
    Bryan T. Hennessy
    Sinead Toomey
    Journal of Translational Medicine, 19
  • [30] HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3
    Ruiz-Saenz, Ana
    Dreyer, Courtney
    Campbell, Marcia R.
    Steri, Veronica
    Gulizia, Nate
    Moasser, Mark M.
    CANCER RESEARCH, 2018, 78 (13) : 3645 - 3658
12345